Viewing nowTitonele Tablet 35 mg (Risedronate Sodium 2.5 Hydrate)
Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Austin Pharmaceutical Co., Ltd.

MFDS item code 200713888 · Notified 2007.12.31 · Insurance code 654303670
Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men
This medication is used for the treatment and prevention of osteoporosis in postmenopausal women and men.
Adults: Administer sodium risedronate 35 mg orally once weekly. No dose adjustment is necessary in older adults (over 60 years) because the bioavailability and pharmacodynamics of this medicine are similar to those in younger people. No dose adjustment is necessary in patients with a creatinine clearance of 30 mL/min or higher. This medicine is contraindicated in patients with severe renal impairment and a creatinine clearance below 30 mL/min. Since food interferes with the absorption of this medicine, for adequate absorption take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after consuming food or beverages. To facilitate passage of this medicine into the stomach and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ∼ 230 mL). Taking this medicine with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. If a patient forgets to take this medicine on the scheduled day, take it the next morning when remembered. Resume the next dose on the originally scheduled day. Do not take 2 tablets on the same day.
The safety and efficacy of this medicine in children under 18 years of age have not been established.
This medication can irritate the gastric and esophageal mucosa, so caution is advised for individuals with gastritis or esophageal disorders. Patients with esophageal issues or difficulty swallowing should avoid this medication. When taking it, consume with plenty of water, and do not lie down for at least 30 minutes after taking. Pregnant or breastfeeding women should not use this drug. Patients with severely impaired kidney function should also avoid this medication. If symptoms such as esophageal pain, difficulty swallowing, or heartburn occur during use, discontinue immediately and consult a doctor. It is important to supplement calcium or vitamin D if deficient. This drug may interfere with the absorption when taken with food or other medications containing calcium or magnesium, so timing should be adjusted. Rare side effects, such as osteonecrosis of the jaw or atypical fractures, may occur with long-term use; consult healthcare professionals if these symptoms arise. Pay attention to oral hygiene while taking this medication, and consult a doctor if invasive dental treatment is needed. Generally safe for the elderly, but should be monitored closely for adverse reactions. In case of overdose, blood calcium levels may drop, so seek medical care if symptoms occur. Safety and efficacy in children under 18 have not been established.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air and moisture. The storage temperature should be maintained at room temperature between 1 degree and 30 degrees Celsius. This helps maintain the medication's effectiveness safely for a long time.
Pale orange rectangular film-coated tablet
4 tablets/PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRisedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Austin Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Nexpam Korea Co., Ltd.

Risedronate Sodium 2.5 Hydrate 35mg
Tablet · Prescription medication
Hyutecs Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.2mg
Tablet · Prescription medication
Celix Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Myeongmun Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.